Barkhof F - Search Results

1

The FAS-670 polymorphism influences susceptibility to multiple sclerosis.

van Veen T, Kalkers NF, Crusius JB, van Winsen L, Barkhof F, Jongen PJ, Peña AS, Polman CH, Uitdehaag BM. van Veen T, et al. Among authors: barkhof f. J Neuroimmunol. 2002 Jul;128(1-2):95-100. doi: 10.1016/s0165-5728(02)00163-7. J Neuroimmunol. 2002. PMID: 12098516

2

Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.

Barkhof F, Scheltens P, Frequin ST, Nauta JJ, Tas MW, Valk J, Hommes OR. Barkhof F, et al. AJR Am J Roentgenol. 1992 Nov;159(5):1041-7. doi: 10.2214/ajr.159.5.1414773. AJR Am J Roentgenol. 1992. PMID: 1414773

3

The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis.

Frequin ST, Barkhof F, Lamers KJ, Hommes OR. Frequin ST, et al. Among authors: barkhof f. J Neuroimmunol. 1992 Oct;40(2-3):265-72. doi: 10.1016/0165-5728(92)90142-8. J Neuroimmunol. 1992. PMID: 1430156 Review.

4

Serial quantitative MR assessment of optic neuritis in a case of neuromyelitis optica, using Gadolinium- "enhanced" STIR imaging.

Barkhof F, Scheltens P, Valk J, Waalewijn C, Uitdehaag BM, Polman CH. Barkhof F, et al. Neuroradiology. 1991;33(1):70-1. doi: 10.1007/BF00593340. Neuroradiology. 1991. PMID: 2027451

5

Partially saturated fluid attenuated inversion recovery (FLAIR) sequences in multiple sclerosis: comparison with fully relaxed FLAIR and conventional spin-echo.

Baratti C, Barkhof F, Hoogenraad F, Valk J. Baratti C, et al. Among authors: barkhof f. Magn Reson Imaging. 1995;13(4):513-21. doi: 10.1016/0730-725x(95)00009-6. Magn Reson Imaging. 1995. PMID: 7674846

6

Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images.

van Walderveen MA, Barkhof F, Hommes OR, Polman CH, Tobi H, Frequin ST, Valk J. van Walderveen MA, et al. Among authors: barkhof f. Neurology. 1995 Sep;45(9):1684-90. doi: 10.1212/wnl.45.9.1684. Neurology. 1995. PMID: 7675227

7

Multiple sclerosis therapy. A practical guide.

van Oosten BW, Truyen L, Barkhof F, Polman CH. van Oosten BW, et al. Among authors: barkhof f. Drugs. 1995 Feb;49(2):200-12. doi: 10.2165/00003495-199549020-00005. Drugs. 1995. PMID: 7729328 Review.

8

Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis.

Barkhof F, Tas MW, Frequin ST, Scheltens P, Hommes OR, Nauta JJ, Valk J. Barkhof F, et al. Neuroradiology. 1994 Jul;36(5):382-7. doi: 10.1007/BF00612124. Neuroradiology. 1994. PMID: 7936181

9

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: statistical power of parallel-groups and crossover designs.

Nauta JJ, Thompson AJ, Barkhof F, Miller DH. Nauta JJ, et al. Among authors: barkhof f. J Neurol Sci. 1994 Mar;122(1):6-14. doi: 10.1016/0022-510x(94)90045-0. J Neurol Sci. 1994. PMID: 8195804

10

T-cell subsets in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients treated with high-dose intravenous methylprednisolone.

Frequin ST, Lamers KJ, Borm GF, Barkhof F, Jongen PJ, Hommes OR. Frequin ST, et al. Among authors: barkhof f. Acta Neurol Scand. 1993 Aug;88(2):80-6. doi: 10.1111/j.1600-0404.1993.tb04195.x. Acta Neurol Scand. 1993. PMID: 8213063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,515 results

Search Page

Filters